Consolidated and Combined Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 595,082	$ 7,227
Tax incentive receivable	15,392	2,633
Prepaid expenses and other current assets	18,300	1,305
Total current assets	628,774	11,165
Property and equipment, net	162	0
Other non-current assets	699	552
Total assets	629,635	11,717
Current liabilities:
Accounts payable	8,065	1,032
Accrued expenses and other current liabilities	16,573	1,047
Convertible term notes	0	5,339
Term loans	0	288
Derivative liability	0	913
Total current liabilities	24,638	8,619
Long term debt	75,700	0
Contingent value rights	37,700	0
Other non-current liabilities	43	0
Total liabilities	138,081	8,619
Commitments and contingencies (Note 7)
Convertible preferred shares (£0.0001 nominal value): No shares authorized, issued and outstanding at December 31, 2021; 6,549,205 shares issued and outstanding at December 31, 2020	0	25,521
Shareholders’ equity and combined deficit:
Series A convertible preferred shares: £0.002 nominal value: 22,840,902 shares authorized. No shares issued and outstanding	0
Ordinary shares: £0.002 nominal value: 152,500,000 shares authorized; 89,988,228 shares issued and outstanding at December 31, 2021; No shares authorized, issued and outstanding at December 31, 2020	252
Additional paid-in capital	876,267
Accumulated other comprehensive income	688
Accumulated deficit	(385,653)
Combined deficit		(22,423)
Total shareholders' equity	491,554
Total combined deficit		(22,423)
Total liabilities, convertible preferred shares, shareholders’ equity and combined deficit	$ 629,635	$ 11,717